Four of the five embolized HNPGLs showing nuclear expression of HIF-2α demonstrated a positivity for PD-L1 in >30% of tumor cells, whereas one embolized HNPGL with nuclear expression of HIF-2α showed a PD-L1 expression in 2% of tumor cells. This evidence concerns the gene EPAS1 and neoplasm.